Ivermectin: Clinical Trials

195 trials of Ivermectin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

123 completed, 38 unknown, 11 terminated, 6 not yet recruiting. 70 Phase 3, 66 Phase 2, 24 Phase 4, 23 Not applicable, 23 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 370Completed 45, Unknown 14, Terminated 4, Not yet recruiting 2, Recruiting 2, Withdrawn 2, Active not recruiting 1
Phase 266Completed 36, Unknown 14, Terminated 6, Recruiting 3, Active not recruiting 2, Not yet recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 424Completed 14, Unknown 6, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Not applicable23Completed 13, Unknown 7, Terminated 2, Recruiting 1
Phase 123Completed 21, Recruiting 1, Unknown 1
Early Phase 16Completed 3, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1

Follow Ivermectin: new trials by email Literature Review of Ivermectin trials Research Report on Ivermectin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
Ivermectin Pill - Atopic Dermatitis
Phase 2WithdrawnStanford University2030-12-012024-12-02
Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)
Intermediate-dose ivermectin, High-dose ivermectin - Solid Tumor, Adult
Phase 2Not yet recruitingUniversity of Florida802026-12-012026-10-13
Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras
Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis
Phase 3Not yet recruitingMundo Sano Foundation3682026-11-012026-06-23
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Topical anti-aging peptide serum - Aging
Early Phase 1Enrolling by invitationFrontiers in Bioscience Research Institute and Aging482026-10-212026-10-22
Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda
Albendazole 400mg, Ivermectin 3 mg - Ascariasis
Phase 3Not yet recruitingJennifer Keiser4502026-10-012026-10-14
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
Ivermectin - Survival of Flies Developing in Faecal Samples
Phase 4Not yet recruitingLondon School of Hygiene and Tropical Medicine122026-07-012026-06-18
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis
Not applicableRecruitingUwemedimo Friday Ekpo57602026-07-012026-07-16
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
Ivermectin, microneedling, Salicylic Acid - Warts
Early Phase 1Not yet recruitingAssiut University882026-02-012026-02-09
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection
Phase 4RecruitingKirby Institute520002025-08-042025-11-21
Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh
A single dose of Albendazole 400mg + Ivermectin (200 µg/ kg) combination therapy, A single dose of 400 mg Oral Albendazole monotherapy - Soil Transmitted Helminth (STH) Infections
Phase 2Enrolling by invitationInternational Centre for Diarrhoeal Disease Research, Bangladesh1102025-07-102025-08-14
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)
Ivermectin Tablets - Scabies; Itch, Scabies
Phase 2Active not recruitingMurdoch Childrens Research Institute1202025-06-242026-10-16
Efficacy of Ivermectin in the Treatment of Plane Warts
Ivermectin, Placebo - Plane Warts
Phase 2CompletedAl-Azhar University802025-06-012026-10-09
Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies
Permethrin Cream, 5%, Ivermectin 200 µg/kg - Scabies
Phase 2Not yet recruitingChildren Hospital and Institute of Child Health, Lahore902025-05-012025-04-20
Co-administration of IVM and ALB in School-based Deworming in Uganda
Albendazole 400mg, Ivermectin 3 MG - Helminthiasis, Intestinal Worms
CompletedJennifer Keiser87672024-07-012024-12-20
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 2CompletedJennifer Keiser2602024-06-052025-09-22
Specific Versus Empirical Anthelminthic Treatment in Eosinophilia
Albendazole, Ivermectin or albendazole - Eosinophilia
Not applicableUnknownPrince of Songkla University7002024-05-012024-09-24
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Ivermectin w/ Albendazole, Ivermectin + Diethylcarbamazine + Albendazole, Moxidectin + Albendazole - Onchocercal Subcutaneous Nodule, Onchocerciasis
Phase 2Active not recruitingWashington University School of Medicine3002024-04-052025-12-18
Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream
Ivermectin cream, Soolantra ® (Ivermectin) cream - Rosacea
Phase 1CompletedHumanis Saglık Anonim Sirketi442024-03-062024-08-20
Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand
Oral Ivermectin, 4% dimenticone liquid gel - Pediculus Capitis Infestation, Permethrin Adverse Reaction
Phase 4UnknownPhramongkutklao College of Medicine and Hospital1172023-12-152024-03-27
Ivermectin Safety in Small Children
Oral ivermectin, Permethrin Cream, Placebo tablet - Scabies
Phase 2CompletedUniversity of Oxford2402023-11-182025-12-18

Showing 20 of 195. Sign in to see all of them.

Conditions studied

COVID-19 (68)  ·  Elephantiasis, Filarial (17)  ·  Onchocerciasis (13)  ·  Scabies (13)  ·  Coronavirus Infections (10)  ·  Malaria (10)  ·  Rosacea (9)  ·  Trichuriasis (8)  ·  Helminthiasis (7)  ·  Severe Acute Respiratory Syndrome (7)  ·  Neglected Diseases (6)  ·  Onchocerciasis, Ocular (6)  ·  Strongyloidiasis (6)  ·  Ascariasis (5)  ·  Hookworm Infections (5)

Sponsors

Jennifer Keiser (9)  ·  London School of Hygiene and Tropical Medicine (8)  ·  Washington University School of Medicine (6)  ·  Mahidol University (5)  ·  Galderma R&D (4)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (4)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (4)  ·  Medicines Development for Global Health (4)  ·  Tanta University (4)  ·  University Hospitals Cleveland Medical Center (4)  ·  Assiut University (3)  ·  DBL -Institute for Health Research and Development (3)  ·  Susanna Naggie, MD (3)  ·  University of Oxford (3)  ·  Ain Shams University (2)

Countries

United States (26)  ·  Egypt (17)  ·  Thailand (12)  ·  Pakistan (9)  ·  Argentina (8)  ·  Côte d’Ivoire (8)  ·  Uganda (7)  ·  Bangladesh (6)  ·  Democratic Republic of the Congo (6)  ·  France (6)  ·  Ghana (6)  ·  United Kingdom (6)  ·  Brazil (5)  ·  Colombia (5)  ·  Burkina Faso (4)

Top investigators

Jerry Cottrell (4)  ·  Adrian Hernandez, MD (3)  ·  Susanna Naggie, MD (3)  ·  Benjamin Koudou, PhD (2)  ·  Brian D. Foy, PhD (2)  ·  Gary J Weil, MD (2)  ·  Gary Weil, MD (2)  ·  Jennifer Keiser, Prof. (2)  ·  Peter U Fischer, PhD (2)  ·  Tony Ukety, MD, DO, MPH (2)  ·  Yupin Suputtamongkol, MD (2)  ·  Aboulaye Miete, MD (1)  ·  Adrian J Wolstenholme, PhD (1)

Results publications

PMID 32251768, PMID 42848323, PMID 23675549, PMID 32293834, PMID 33227231, PMID 33234158, PMID 34473343, PMID 35180412, PMID 37262040, PMID 37489818, PMID 37949090, PMID 39308445, PMID 39356094, PMID 12474486, PMID 12592987, PMID 15992957, PMID 16103202, PMID 16287208, PMID 16681635, PMID 16713738, PMID 17399779, PMID 17426180, PMID 18414647, PMID 18446504, PMID 18564693, PMID 18809192, PMID 19081121, PMID 19265242, PMID 19571614, PMID 19589144, PMID 20220184, PMID 21353271, PMID 21572981, PMID 21885077, PMID 22073495, PMID 22417684, PMID 23647969, PMID 23769930, PMID 23981378, PMID 24161512, PMID 24968000, PMID 25108173, PMID 25877874, PMID 26393130, PMID 26401658, PMID 26486704, PMID 26744590, PMID 26752081, PMID 26827134, PMID 26988202

NIH funding

U24TR001608 (3), 2015 (1), 2023 (1), U01AI138910 (1), UL1TR000124 (1)